Abstract
The study describes the effects of 10-wk dietary supplementation with fructans (inulin and oligofructose, 5% and 10%, respectively) as well as the biomimetic Cr(III) propionate complex (0.5 and 5 mg Cr/kg diet) on blood glucose, insulin, glucose transmembrane transport, and β-oxidation of fatty acids in healthy male rats. No significant differences in blood serum glucose concentrations were found. Rats fed diets supplemented with the biomimetic complex (5 mg Cr/kg diet) had markedly decreased serum insulin level by 15%, whereas the red blood cells (RBCs) glucose transmembrane transport and β-oxidation of fatty acids in white blood cells (WBCs) were elevated by 9% and 77%, respectively. These effects were accompanied by a slight decrease of the insulin-resistance index. Oligofructose and the high-fructan diet (10%) were more effective in increasing the RBCs glucose transmembrane transport vs inulin and lowfructan diet (5%). Also, β-oxidation of fatty acids in WBCs was increased by 37.5% in groups fed the high-fructan diet (10%). The results suggest that dietary fructans and the biomimetic Cr(III) complex exerted beneficial effects on glucose and lipid metabolism, increasing the efficiency of their utilization.
Similar content being viewed by others
References
R. A. Anderson, M. M. Polansky., N. A. Bryden, and J. J. Canary, Supplementalchromium effects on glucose, insulin, glucagon and urinary chromium losses in subjects consuming controlled low-chromium diets. Am. J. Clin. Nutr., 54, 909–916 (1991).
R. A. Anderson, Chromium, glucose intolerance and diabetes, J. Am. Coll. Nutr., 17, 548–555 (1998).
K. Balamurugan, R. Rajaram, T. Ramasami, and S. Narayanan, Chromium (III) induced apoptosis of lymphocytes: death decision by ROS and Src-family tyrosine kinases, Free Radical Biol. Med., 33, 1622–1640 (2002).
A. Ostman and F.-D. Bohmer, Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases, Trends Cell Biol., 11, 258–266 (2001).
M. Lipko, T. Kuryl, and B. Dêbski, Reactive oxygen species are involved in chromium(III) and insulin induced glucose uptake in cultured muscle cells, in Vitamine und Zusatzstoffe in der Ernarung von Mensch und Tier, M. Anke (Ed.), Friedrich-Schiller-Universitat, Jena, pp. 355–358 (2003).
J. L. Shelton, R. L. Payne, S. L. Johnston, et al. Effect of chromium propionate on growth, carcass trait, pork quality and plasma metabolites in growing-finishing pigs. J. Anim. Sci., 81, 2515–2524 (2003).
A. Pechova, S. Cech, L. Pavlata, and A. Podhorsky; The influence of chromium supplementation on metabolism, performance and reproduction of dairy cows in a herd with increased occurrence of ketosis, Czech. Anim. Sci., 48, 349–358 (2003).
J. B. Vincent, Recent developments in the biochemistry of chromium(III), Biol. Trace Element Res., 99, 1–16 (2004).
B. J. Clodfelder, C. Chang, and J. B. Vincent, Absorption of the biomimetic Chromium cation triaqua-μ3-oxo-μ-hexapropionatotrichromium(III) in rats. Biol. Trace Element Res. 97, 1–11 (2004).
J. K. Speetjens, R. A. Collins, J. B. Vincent, and S. A. Woski, The nutritional supplement chromium(III) tris(picolinate) cleaves DNA, Chem. Res. Toxicol., 12, 483–487 (1999).
J. K. Speetjens, A. Parand, M. W. Crowder, and J. B. Vincent, Low-molecular-weight, chromium-binding substance and biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ do not cleave DNA under physiologically relevant conditions. Polyhedron, 18, 2617–2624 (1999).
D. M. Stearns, J. P. Wise, S. R. Patierno, and K. E. Wetterhahn, Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells FASEB J. 9, 1643–1648 (1995).
C. M. Davis, and J. B. Vincent, Chromium in carbohydrate and lipid metabolism, J. Biol. Inorg. Chem., 2, 675–679 (1997).
J. B. Vincent, Recent advances in the biochemistry of chromium, J. Trace Elements Exp. Med., 16, 227–236 (2003).
J. B. Vincent, The bioinorganic chemistry of chromium(III), Polyhedron, 20, 1–26 (2001).
T. Kuryl, M. Lipko, and B. Debski, Metabolism of fatty acids in broiler chicken is affected by chromium, in Metal Ions in Biology and Medicine, L. Khassanova, P. Collery, I. Maymard, Z. Khassanova, and J.-C. Etienne eds., John Libbey CIC, Rome, Vol. 7, Part X, pp. 454–459 (2002).
O. Wada, G. Y. Wu, A. Yamamoto, S. Manabe, and T. Ono, Purification and chromiumexcretory function of low-molecular weight chromium binding substances from dog liver, Environ. Res., 32, 228–239 (1983).
G. W. Evans, and T. D. Bowman, Chromium picolinate increases membrane fluidity and rate of internalization, J. Inorg. Biochem., 46, 243–250 (1992).
M. Lipko, A. Orzechowski, T. Kuryl, and B. Dębski, Influence of chromium on glucose uptake in mouse myotubes, in Mengen- und Spurenelemente, 21 Arbeitstagugn, 2002, Friedrich Schiller-Universitat, Jena, M. Anke et al. (Eds.), Schubert Verlag, Leipzig, pp. 560–566 (2002).
C. Cherbut, Inulin and oligofructose in the dietary fiber concept, Br. J. Nutr., 87, 159–162 (2002).
E. Sawosz, Znaczenie chromu (Cr+3) w zywieniu zwierzat. Dietetyka 441–443 (1999) (in Polish).
F. Brighenti, M. C. Casiraghi, E. Canci, and A. Ferrari, Effect of consumption of a readyto-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur. J. Clin. Nutr., 53, 726–733 (1999).
D. Letexier, F. Diraison, and M. Beylot, Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in human. Am. J. Clin. Nutr., 77, 559–564 (2003).
P. G. Reevens, H. Nielsen, and G. C. Fahey, AIN-93. Purfield diets for laboratory rodents. Final report of the American Institute of Nutrition ad hoc writing Committee on the Reformulation of the AIN-76 A rodent diet, J. Nutr., 123, 1939–1951 (1993).
A. Earnshaw, B. N. Figgis, and J. Lewis, Chemistry of polynuclear compounds. Part VI. Magnetic properties of timer chromium and iron carboxylates, J. Chem. Soc. A 1656–1663 (1966).
T. Kuryl, M. Adamowicz, B. Dêbski, J. Bertrandt, and K. Martinik, Degradation of [9, 10]-3H-myristic acid by lymphocytes. Screening test of inherited disorders of activation, transport and mitochondrial oxidation of fatty acids, Aterosclerosa 23–26 (2001).
D. R. Matthews, J. P. Hosker, A. S. Rudeski, B. A. Naylor, D. F. Treacher, and R. C. Turner, Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologin 28, 421–429 (1985).
A. Yamamoto, O. Wada, and T. Ono. Isolation of biologically active low-molecularmass chromium compound from rabbit liver, Eur. J. Biochem., 165, 627–631 (1987).
Y. Sun, J. Ramirezs, S. A. Woski, and J. B. Vincent, The binding of trivalent chromium to low-molecular-weight chromium binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWC. J. Biol. Inorg. Chem., 5, 129–136 (2000).
B. J. Clodfelder, J. Emamaullee, D. D. Hepburn, N. E. Chakov, H. S. Nettles, and J. B. Vincent, The trial of chromium(III) in vitro from the blood to the urine: the roles of transferrin and chromodulin, J. Biol. Inorg. Chem., 6, 608–617 (2001).
C. M. Davis, K. H. Sumrall, and J. B. Vincent, The biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP), Biochemistry, 35, 12,963–12,969 (1996).
C. M. Davis, A. C. Royer, and J. B. Vincent, Synthetic multinuclear chromium assembly activates insulin receptor kinase activity: functional model for low-molecular-weight chromium-binding substance, Inorg. Chem., 36, 5316–5320 (1997).
W. W. Campbell, L. J. O. Joseph, S. L. Davey, D. Cyr-Campbell, R. A. Anderson, and W. J. Evans, Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men, J. Appl. Physiol., 86, 29–39 (1999).
L. S. Walker, M. G. Bemben, D. A. Bemben, and A. W. Knehans, Chromium picolinate effects on body composition and muscular performance in wrestlers, Med. Sci. Sports. Exerc., 30, 1730–1737 (1998).
R. A. Anderson, N. A. Brygden, and M. M. Polansky, Lack of toxicity of chromium chloride and chromium picolinate in rats, J. Am. Coll. Nutr., 6, 273–279 (1997).
R. A. Anderson, Essentiality of chromium in humans, Sci. Total Environ., 86, 75–81 (1989).
Y. Sun, B. J. Clodfelder, A. A. Shute, T. Irvin, and J. B. Vincent, The biomimetic [Cr3O (O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J. Biol. Inorg. Chem., 7, 852–862 (2002).
B. J. Clodfelder, B. M. Gullick, H. C. Lukaski, Y. Neggers, and J. B. Vincent, Oral adminstration of the biomimetic [Cr3O(C2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats, J. Biol. Inorg. Chem., 10, 119–130 (2005).
M. Williams, Effects of inulin on lipid parameters in human. J. Nutr., 129, 1471–1473 (1999).
M. Williams and K. G. Jackson, Inulin and oligofructose: effects on lipid metabolism from human studies, Br. J. Nutr., 87, 261–264 (2002).
N. M. Delzenne and N. N. Kok, Effects of fructans-type of prebiotics on lipid metabolism, Am. J. Clin. Nutr., 73, 456–458 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuryl, T., Krejpcio, Z., Wójciak, R.W. et al. Chromium (III) Propionate and dietary fructans supplementation stimulate erythrocyte glucose uptake and beta-oxidation in lymphocytes of rats. Biol Trace Elem Res 114, 237–248 (2006). https://doi.org/10.1385/BTER:114:1:237
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:114:1:237